MedPath

SCIOTEC Diagnostic Technologies GmbH

🇦🇹Austria
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:1
Completed:2

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Observational Study on the Safety and Efficacy of the Medical Product Fructosin.

Not yet recruiting
Conditions
Fructose Intolerance
First Posted Date
2023-09-21
Last Posted Date
2023-09-21
Lead Sponsor
Sciotec Diagnostic Technologies GmbH
Target Recruit Count
60
Registration Number
NCT06044389
Locations
🇦🇹

Sciotec Diagnostic Technologies GmbH, Tulln, Niederösterreich, Austria

Study to Investigate the Effect of an Oral Diamine Oxidase Substitution (DAOsin) in Histamine Intolerant Patients on the Low Endogenous Diamine Oxidase Serum Activity

Not Applicable
Completed
Conditions
Histamine Intolerance
Food Intolerance
First Posted Date
2017-10-02
Last Posted Date
2018-04-17
Lead Sponsor
Sciotec Diagnostic Technologies GmbH
Target Recruit Count
30
Registration Number
NCT03298568
Locations
🇦🇹

Ordination für Innere Medizin und Stoffwechselzentrum, Bruck an der Mur, Austria

Efficacy of Fructose Metabolizing Enzymatic Product in Fructose Malabsorption

Not Applicable
Completed
Conditions
Fructose Malabsorption
First Posted Date
2009-06-09
Last Posted Date
2010-12-20
Lead Sponsor
Sciotec Diagnostic Technologies GmbH
Target Recruit Count
65
Registration Number
NCT00916487
Locations
🇦🇹

Medical University of Graz, Graz, Styria, Austria

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.